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Changes in cytosolic calciumare crucial for numerous
processes including neuronal plasticity. This study in-
vestigates the regulation of cytosolic calciumby corti-
cotropin-releasing factor (CRF) in midbrain dopamine
neurons. The results demonstrate that CRF stimulates
the releaseof intracellular calciumfromstores through
activation of adenylyl cyclase and PKA. Imaging and
photolysis experiments showed that the calcium
originated fromdendrites and requiredboth functional
IP3 and ryanodine receptor channels. The elevation in
cytosolic calcium potentiated calcium-sensitive po-
tassium channels (sK) activated by action potentials
and metabotropic Gq-coupled receptors for gluta-
mate and acetylcholine. This increase in cytosolic cal-
cium activated by postsynaptic Gs-coupled CRF re-
ceptors may represent a fundamental mechanism by
which stress peptides and hormones can shape Gq-
coupled receptor-mediated regulation of neuronal ex-
citability and synaptic plasticity in dopamine neurons.
INTRODUCTION
In both in neurons and nonneuronal cells, changes in the concen-
trations of cytosolic (free) calcium regulate diverse processes in-
cluding hormone secretion (Verkhratsky, 2005), cytoskeletal re-
arrangement (Spira et al., 2001), gene expression (West et al.,
2001), receptor trafficking (Ziff, 2007), and neuronal plasticity
(Ghosh and Greenberg, 1995). Calcium enters the cytosol from
two spatially distinct sources: intracellular stores and the extra-
cellular space (Bootman et al., 2000). Intracellular stores release
calcium through channels located on the endoplasmic reticulum
membrane such as the inositol triphosphate (IP3) receptor and
the ryanodine receptor (Choi et al., 2006; Foskett et al., 2007).
IP3 receptors are recruited following activation of Gq-protein
coupled receptors and phospholipase C (PLC). Calcium release
from IP3 receptors activates ryanodine receptor channels
through calcium-induced calcium-release (Augustine et al.,
2003). Calcium entry from the extracellular space occurs through
voltage-gated calcium channels that are activated upon depolar-
ization. Increases in cytosolic calcium originating from both
sources can activate intrinsic conductances, including small
conductance calcium-activated potassium (sK) channels thatare involved in synaptic integration and spike frequency adapta-
tion (Bean, 2007; Bond et al., 1999; Womack et al., 2004).
Mesocorticolimbic dopamine neurons, which originate from
the ventral tegmental area and substantia nigra, encode signals
important for movement and reinforcing behaviors such as drug
abuse (Bjorklund and Dunnett, 2007; Grace et al., 2007; Wise,
2004). Recent studies implicate corticotropin-releasing factor
(CRF) in many central actions of drugs of abuse (Sarnyai et al.,
2001). CRF is a 41 amino acid peptide that mediates behavioral
responses to stress through coordinated actions at two Gs-
coupled protein receptors (CRF-1 and CRF-2) (Chen et al.,
1993; Stenzel et al., 1995). CRF functions as a hormone within
the hypothalamic pituitary axis (Hauger et al., 2006), but is also
synthesized and released in areas outside the hypothalamus (Or-
ozco-Cabal et al., 2006; Swanson et al., 1983). In nonneuronal
cells, CRF and many other hormones increase cytosolic calcium
through protein kinase A (PKA)- and PKC-dependent actions at
internal stores and voltage gated calcium channels on the
plasmamembrane (Dermitzaki et al., 2004; Petersen et al., 1994).
CRF receptors are present on midbrain dopamine neurons,
but their impact on neuronal excitability remains poorly under-
stood (Van Pett et al., 2000). For instance, blockade of CRF
receptors generates either no effect or decreases cocaine-
induced dopamine release from terminals in the accumbens
(Lodge and Grace, 2005; Lu et al., 2003). However, CRF may
stimulate the release of dopamine in other brain regions and in-
creases DA neuron firing (Korotkova et al., 2006; Lavicky and
Dunn, 1993). Known actions of CRF on dopamine neurons in-
volve the CRF-binding protein, PKC, and voltage gated calcium
channels (Kim et al., 2007; Ungless et al., 2003). A CRF-mediated
increase in concentrations of cytosolic calcium in dopamine neu-
rons has not been reported. However, the release of calcium
from intracellular stores in dopamine cells activates an sK con-
ductance following synaptic activation of metabotropic gluta-
mate receptors (mGluRs) (Fiorillo and Williams, 1998; Morikawa
et al., 2003), alpha-1-adrenergic receptors (Paladini and Wil-
liams, 2004), and muscarinic receptors (Fiorillo and Williams,
2000). Moreover, calcium entry during action potentials results
in an increase in an sK-dependent conductance (Cui et al.,
2007; Wolfart et al., 2001; Wolfart and Roeper, 2002). Such ob-
servations raise the possibility that in dopamine neurons, CRF
could regulate sK-dependent currents by influencing the calcium
associated with intracellular stores, calcium entry through volt-
age dependent channels, or both.
This study investigates the regulation of cytosolic calcium
concentrations by CRF receptors in dopamine neurons. TheNeuron 57, 559–570, February 28, 2008 ª2008 Elsevier Inc. 559
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calcium from stores through activation of adenylyl cyclase and
PKA. This release of calcium is sufficient to potentiate the sKchan-
nel inhibition mediated by Gq-coupled receptors. The increase in
calcium release from intracellular storesmediatedbyGs-activation
may represent a fundamental mechanism by which stress pep-
tides in particular and various hormones in general can shape the
neuronal excitability and synaptic plasticity of dopamine neurons.
RESULTS
CRF Increases the Current Induced by mGluRs
The synaptic activation of mGluRs results in an outward current
(IPSC) that is mediated by an increase in calcium-sensitive
potassium conductance. Superfusion of CRF (300 nM) caused
a significant increase in the amplitude of the inhibitory postsyn-
aptic current (IPSC) mediated by the mGluR (230% ± 21% of
control, n = 8; Figures 1A and 1B; p < 0.05). Likewise, CRF almost
doubled the amplitude of the current induced by iontophoretic
application of aspartate (182%±22%of control, n = 6; Figure 1B;
p < 0.05). In each experiment, the stimulus was adjusted such
that the amplitude of the IPSC or outward current was less
than 30% of the maximum such that the CRF-induced increase
in current did not saturate the potassium conductance. The
increase in both the IPSC and the current induced by aspartate
peaked at 6 min following the onset of the CRF treatment
and occurred without alteration in the holding current (control,
31 ± 3.8 pA; CRF, 34 ± 4 pA, n = 12; p > 0.05). At the end
of the experiment apamin (100 nM) was used to block both cur-
rents. A second agonist specific for CRF-2 receptors, urocortin-
III (UCN-III, 300 nM), produced a similar augmentation of both
the IPSC (223% ± 18% of control, n = 6; p < 0.05) and aspartate
induced current (189% ± 15% of control, n = 5; p < 0.05; Fig-
ure 1). Application of UCN-III alone did not alter the holding cur-
rent (control,63 ± 10 pA; UCN-III,70 ± 11 pA, n = 6; p > 0.05).
Concentration Dependence of CRF
The concentration dependence of CRF was evaluated over
a range of 1–300 nM. In this experiment, the current induced by
iontophoretic application of aspartate was used to avoid any po-
tential presynaptic effects of CRF. At higher concentrations, the
CRF-potentiation peaked within 6–8 min (300 nM CRF, 200% ±
39% at 6 min, n = 8; 100 nM CRF, 202% ± 18% at 8 min, n = 5;
in all instances p < 0.05 versus baseline; Figure 2A). Thereafter,
the current declined despite the continued presence of CRF.
The attenuation of the aspartate-induced current resembled
the heterologous desensitization of sK current reported previ-
ously (Paladini et al., 2004). Lower concentrations of CRF (1–30
nM) generated an increase of the aspartate-induced current
that developed over a prolonged period and failed to plateau
even after 20 min (Figure 2A; 30 nM, 200% ± 44% at 20 min,
n = 6; 3 nM, 182% ± 25% at 20 min, n = 6; 1 nM, 162% ± 12%
at 20 min, n = 5; in all instances p < 0.05 versus baseline). In all
subsequent experiments CRF (300 nM) was applied for 6–8 min.
CRF Activates CRF-R2
To determine which receptor subtype(s) modulate mGluR
responses, CRF was tested in the presence of antagonists for
560 Neuron 57, 559–570, February 28, 2008 ª2008 Elsevier Inc.CRF-R1 (antalarmin) or CRF-R2 (antisauvagine-30). Antalarmin
(1 mM; incubation > 20 min) did not reduce the CRF potentiation
(CRF, 182% ± 22%, n = 6; CRF + antalarmin, 215 ± 65 pA, n = 6;
p > 0.05; Figure 2B). In contrast, inclusion of antisauvagine-30
(1 mM; incubation > 10 min) completely blocked CRF-evoked
increases in the current induced by iontophoretic application of
aspartate (CRF, 200% ± 39%, n = 8; Figure 2A; CRF + antisau-
vagine-30, 106% ± 15%, n = 6; Figure 2B; p < 0.05; Jahn
et al., 2004). Antisauvagine-30 alone did not alter aspartate-
induced currents or disrupt the facilitation induced by NS309
(10 mM), a stabilizer of the sK channel (antisauvagine-30, 100%
± 7%, n = 6; antisauvagine-30 + NS309, 217% ± 26%, n = 6; Fig-
ure 2B; p < 0.05). Neither antisauvagine-30 nor antalarmin
altered the holding current (control, 58 ± 14 pA; antisauva-
gine-30, 50 ± 11 pA, n = 6, p > 0.5; control, 63 ± 11 pA; ant-
alarmin, 50 ± 18 pA, n = 6, p > 0.5). These results suggest that
the CRF-R2 subtype induced the modulation of mGluR-depen-
dent current.
Interactions between CRF, CRF-R2,
and the CRF-Binding Protein
In addition to CRF receptors, CRF binds to the CRF-binding pro-
tein, which regulates the actions of CRF by buffering the amount
of free CRF in the extracellular compartment. Slices were
Figure 1. Activation of CRF Receptors Potentiates an Outward Cur-
rent Evoked by the Activation of Metabotropic Glutamate Receptors
(A) Raw traces of an IPSC and outward current induced by the iontophoretic
application of aspartate (L-Asp) in control and in the presence of CRF (300 nM).
(B) Summarized results showing the time course of the facilitation of the IPSC
and outward current. At the end of each experiment the sK channel antagonist
apamin (APA, 100 nM) was applied to block the current.
(C) Raw traces of an IPSC and outward aspartate-evoked current before and
after treatment with the CRF-2 agonist urocortin-III (UCN-III, 300 nM).
(D) Summarized results showing the time course of facilitation induced by
urocortin-III and subsequent block by apamin.
All data in (B) and (D) are expressed as a percent of control. Error bars indicate
SEM.
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CRF Stimulates Release of Intracellular Calciumsuperfused with CRF6-33 (1 mM), a competitive inhibitor of the
CRF-binding protein, resulting in an increase in the aspartate
induced current (baseline, 99% ± 2%, n = 6; CRF6-33, 157% ±
23%, n = 6; Figure 1C; p < 0.05). The potentiation induced by
CRF6-33 was blocked after preincubation of the slice with anti-
sauvagine-30 (1 mM; CRF6-33, 157% ± 23% n = 6; CRF6-33 +
antisauvagine-30, 98% ± 5%, n = 5; Figure 2C; p < 0.05), but
not after incubation with antalarmin (1 mM, CRF6-33, 157% ±
23% n = 6; CRF6-33 + antalarmin, 167% ± 11%, n = 5; p > 0.05;
not shown). These results suggest that CRF6-33 may displace/
release endogenous CRF into the extracellular space, resulting
in the activation of CRF-R2 to increase the mGluR current.
Antisauvagine-30 blocked the actions of CRF and CRF6-33,
but did not block the increase in sK current induced by forskolin
(3 mM, CRF6-33 + antisauvagine-30, 107% ± 11%, n = 6; forsko-
lin + CRF6-33 + antisauvagine-30, 176% ± 19%, n = 3; p < 0.05;
not shown). Thus, blockade of the R2-CRF receptor did not pre-
vent the increase induced by forskolin that acts on a process
downstream of the receptor.
CRF Acts through Adenylyl Cyclase and Protein
Kinase A (PKA)
CRF receptors are known to be Gs coupled (Hsu and Hsueh,
2001; Jahn et al., 2004; Lewis et al., 2001). The actions of CRF
Figure 2. The Pharmacology of CRF: Concentration Depen-
dence, Receptor Subtype, and Interactions with the CRF-Bind-
ing Protein
(A) Concentration dependence: traces, raw data showing the current
induced by iontophoretic application of aspartate in control and CRF
(3 nM, left; 30 nM, right). Summarized results showing potentiation of
the aspartate-evoked current induced byCRF (3, 30, 300 nM) as a function
of time (n = 6, 6, 8, respectively). Lines were drawn by eye.
(B) CRF receptor subtype: left trace, antalarmin (AA, 1 mM; incubation >
25 min) did not block the CRF (300 nM)-induced increase in aspartate cur-
rent. Right trace, in a different cell, the CRF-R2 antagonist antisuavagine-
30 (ASV, 1 mM; incubation >10 min) blocked the potentiation by CRF (300
nM). ASV did not block the potentiation evoked by NS309 (10 mM). Time-
course, summarized results showing the actions of CRF (300 nM) and
NS309 (10 mM) on the aspartate evoked current in the presence of ASV
(1 mM, n = 6).
(C) CRF-binding protein: left trace, potentiation of the aspartate-evoked
current by CRF6-33 (1 mM), a CRF-binding protein inhibitor. Right trace,
inclusion of CRF-R2 antagonist antisuavagine-30 (ASV, 1 mM; incubation
>10 min), blocked the potentiation by CRF6-33 (1 mM). ASV did not block
the potentiation evoked by forskolin (3 mM). Ttime-course, summarized
results showing the actions of CRF6-33 (1 mM) in the presence (n = 5) or
absence of ASV (1 mM; n = 9).
Data in time-courses (A)–(C) are expressed as a percent of control. Error
bars indicate SEM.
were compared with the effect of forskolin, a potent activator
of adenylyl cyclase. In this experiment, the current induced
by iontophoretic application of aspartate was used because
forskolin facilitates the presynaptic release of glutamate
(Manzoni and Williams, 1999). In the initial experiments, the
actions of CRF (300 nM) on the mGluR-induced current
were tested prior to the application of forskolin (Figures 3A
and 3B). CRF increased the sK current (to 177% ± 17%
from baseline, 99% ± 2%, n = 14; Figure 3B; p < 0.05) and
because forskolin is a powerful activator of adenylyl cyclase it
was capable of causing an additional potentiation of the current
(forskolin, 3 mM, 265% ± 23% of baseline, n = 9; Figure 3B;
p < 0.05). Forskolin alone did not significantly alter the holding
current (control, 23 ± 13 pA; forskolin, 38 ± 15 pA, n = 9,
p > 0.05; not shown). Application of forskolin following washout
of CRF resulted in a larger forskolin-induced increase in the sK
current than forskolin application without prior CRF application
(forskolin alone, 187% ± 16% of baseline, n = 8, Figure 3D, com-
pared with 265% ± 23% of baseline following CRF, Figure 3B;
p < 0.05). When forskolin (3 mM) was applied for 12 min and im-
mediately followed by an application of CRF (300 nM), CRF had
no additional effect (CRF after forskolin, 198% ± 21%, n = 6, Fig-
ure 3D; CRF alone, 181% ± 22%, n = 6, Figure 3B; p > 0.05). The
observation that CRF had no additional effect following treat-
ment with forskolin indicates that this action of CRF may be me-
diated by an activation of adenylyl cyclase. The lack of a further
action of CRF was not limited by the potassium conductance,
first because the initial current induced by aspartate was less
than 30% of the maximum. Second, at the end of the experiment
a longer application of aspartate further increased the outward
current (322% ± 31% of baseline, n = 4, not shown).
During a 10–15 min application of forskolin, the increase in IsK
peaked and thereafter declined (Figures 3C and 6B). This result
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concentration of CRF (300 nM; Figure 2A).
The role of protein kinase A (PKA) in the action of CRF and
forskolin was tested using the pseudo-substrate blocker protein
kinase inhibitor (PKI) (Scott et al., 1985, 1986). The PKI was in-
cluded in the intracellular solution and cells were equilibrated be-
fore CRF and forskolin were tested. After equilibration with PKI,
neither CRF (4% ± 17% change, n = 8) nor forskolin (10% ± 15%
change, n = 8) caused any significant change in the current in-
duced by aspartate (Figures 3A and 3B). The holding current
and the current induced by aspartate were not affected by the
addition of PKI to the pipette solution. The potassium conduc-
tance could still be increased, because a stabilizer of sK-chan-
nels, NS309, tested at the end of these experiments caused an
increase in the current (Pedarzani et al., 2005; Strobaek et al.,
2004). Application of NS309 (10 mM) increased the current
(204% ± 18%, n = 5, p < 0.05 versus baseline) in the presence
of PKI (Figures 3A and 3B). The inactive analog of forskolin
1,9-dideoxyforskolin (3 mM) had no effect on the aspartate-
induced current (104% ± 4%, n = 5; baseline, 99% ± 4%, n = 5;
Figure 3C; p > 0.05). Likewise, when phorbol-ester-dybutyrate
(PDBu) was used to activate protein kinase C (PKC), the current
induced by aspartate was not changed (106%± 7%, n = 5; base-
line, 99% ± 4%, n = 5; Figure 3C; p > 0.05). Thus, both CRF and
forskolin enhanced the mGluR-mediated outward current by
a PKA-dependent mechanism.
Activation of Adenylyl Cyclase Increased
Calcium in Dendrites
In dopamine neurons, the outward current induced by activation
of metabotropic glutamate receptors is dependent on the re-
lease of calcium from intracellular stores (Morikawa et al.,
2003). The increase in the current induced by CRF or forskolin
could result from a number of different mechanisms including
an increase in the release of calcium from intracellular stores
or an increase in the sensitivity of the calcium-sensitive potas-
sium channel for calcium.
These potential mechanisms were tested first by measuring
the rise and fall in intracellular calcium induced by aspartate be-
fore and during application of forskolin (3 mM; Figures 4 and 5).
Forskolin increased both the outward current induced by aspar-
tate (control, 28.9 ± 3.6 pA, n = 12; forskolin, 71.6 ± 9.3 pA,
n = 12; p < 0.001, Figure 5A) and simultaneously increased the
dendritic calcium transients (DG/R; control, 1.90 ± 0.36%,
n = 12; forskolin, 3.32% ± 0.54%, n = 12; p < 0.05; Figure 5B).
The facilitation of calcium was dendritic in origin at or near the
point where the initial rise in calcium was evoked.
These results suggest that the increase in sK conductance in-
duced by forskolin results from an increased release of calcium.
One possibility is that there is a PKA-dependent effect directly on
the metabotropic glutamate receptor. The effect of forskolin was
therefore tested on a second phosphatidylinositol (PI)-coupled
receptor, i.e., the M1-muscarinic receptor. Activation of M1 re-
ceptors results in the release of calcium from intracellular stores
and the activation of a calcium-dependent outward sK current
(Fiorillo and Williams, 2000). Iontophoresis of acetylcholine
(ACh), in the presence of the nicotinic acetylcholine receptor an-
tagonist, hexamethonium (200 mM), caused an outward current
and a transient rise in calcium (Figures 5C and 5D). Forskolin in-
creased the ACh-induced current (control, 24.6 ± 3.1 pA, n = 5;
forskolin, 78.0 ± 6.9 pA, n = 5; p < 0.001) and the rise in intracel-
lular calcium (DG/R control, 1.13% ± 0.29%, n = 5; forskolin,
2.58% ± 0.47%, n = 5; p < 0.05).
Next, the activation of PI-coupled receptors was bypassed,
and an increase in intracellular calcium was evoked by depola-
rizing the cell to 0 mV for 50–200 ms. The resulting apamin-
sensitive outward current was measured upon repolarization
to 60 mV (Cui et al., 2007; Wolfart et al., 2001). Forskolin
increased this outward current (control, 154 ± 28 pA, n = 4; for-
skolin, 306 ± 51 pA, n = 4, p < 0.05; not shown) and the calcium
Figure 3. The CRF Potentiation of Metabotropic Glutamate
Receptor (mGluR)-Induced Current Is Mediated by Adenylate
Cyclase and PKA
(A1) (Left side) Raw traces of the current induced by iontophoretic applica-
tion of aspartate (L-Asp) in control, in the presence of CRF (300 nM), and in
the presence of forskolin (3 mM). (A2) (Right side) Raw traces taken from an
experiment where the pseudo-substrate blocker PKI (1 mM) was included
in the internal solution. The aspartate induced current was not changed by
either CRF or forskolin but was increased by NS309 (10 mM), a stabilizer of
sK channels.
(B) Summarized results showing in control the time course of the potenti-
ation of the aspartate-evoked current by CRF (n = 14) and forskolin (n = 9).
Inclusion of PKI in the internal solution blocked this potentiation (CRF,
n = 8; forskolin, n = 8). All currents were inhibited by the sK channel antag-
onist, apamin (APA, 100 nM).
(C) Summarized results showing the facilitation of the aspartate-induced
current by forskolin (3 mM, n = 8), but not the inactive analog dideoxy-
forskolin (3 mM, n = 5) or the PKC activating phorbol ester, PDBu (300 nM,
n = 6).
(D) Summarized result showing the increase in aspartate induced current
caused by forskolin (3 mM) and the occlusion of an increase induced by
CRF (300 nM, n = 6).
Data in time courses (B–D) are expressed as a percent of control. Error
bars indicate SEM.
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0.22%, n = 4; forskolin, 1.8% ± 0.12%, n = 4; p < 0.05; not
shown).
Thus, forskolin had the same action to increase the sK current
and intracellular calcium transient following stimulation of me-
tabotropic glutamate and M1-muscarinic receptors as well as
the outward current induced by calcium entry through voltage-
dependent calcium channels. It is therefore likely that the target
of PKA-phosphorylation is not Gq-coupled receptors.
The Potentiation Does Not Require
Extracellular Calcium
The results suggest that activation of adenylyl cyclase increases
the calcium transient to facilitate the activation of the apamin-
sensitive potassium current. To determine the role of extracellu-
lar calcium, the ability of forskolin and CRF to increase the aspar-
tate-induced current was examined in calcium-free solution (with
EGTA, 500 mM, Figure 6). The aspartate-induced current was not
significantly reduced during treatment with the calcium-free so-
lution for 10 min (baseline, 100% ± 5%, n = 10; calcium-free,
83% ± 8%, range 66%–107%, n = 10; p > 0.05). Both CRF
and forskolin caused an increase in the current in calcium-free
solution (forskolin, 244% ± 10%, n = 5, p < 0.05 versus baseline;
p < 0.05 versus calcium-free; CRF, 186% ± 11%, n = 5, p < 0.05
versus baseline; p < 0.05 versus calcium-free; Figure 6B). The
result suggests that the PKA-mediated facilitation of IsK was
not dependent on extracellular calcium.
Dependent on Intracellular Calcium
Although the forskolin-induced increase in outward current was
accompanied by an increase in intracellular calcium, it was pos-
sible that the sensitivity of the potassium channel to calciumwas
also increased. A transient increase in Intracellular calcium was
induced using photolytic release of calcium from caged-calcium
(NP-EGTA). The intracellular solution contained NP-EGTA
(1.5 mM), and calcium-induced outward currents were evoked
by photolysis every 2 min.
The outward current induced by the uncaging of calcium was
stable over time and in all instances was eliminated by apamin
(100 nM, not shown). Both CRF and forskolin (Figures 7A and
7B) increased the outward current induced by calcium photoly-
sis (CRF, 146% ± 29%, n = 5; forskolin, 155% ± 16%, n = 6; Fig-
ures 7 A and 7B; p < 0.05 agonist versus baseline). Application of
NS309 (10 mM) to stabilize the sK channel produced a further sig-
nificant increase in the outward current (CRF + NS309, 197% ±
51%, n = 5; forskolin + NS309, 215% ± 44%, n = 5; Figures 7A
and 7B; p < 0.05). These results do not rule out a direct action
of PKA on the potassium channel.
The involvement of intracellular calcium stores in calcium-de-
pendent calcium release was examined by depleting intracellular
stores with cyclopiazonic acid (CPA, 10 mM). Treatment with
CPAalone produced a significant decrease in the outward current
inducedby the photolysis of cagedcalcium (Figures 7Cand 7D; to
72% ± 10% of baseline, n = 10; p < 0.05). This observation indi-
cated that the photolytic release of calcium resulted in a further re-
lease of calcium from intracellular stores.OnceCPA had depleted
internal stores, neither CRF nor forskolin had an effect (Figures 7C
and 7D). After treatment with CPA, NS309 caused a significant in-
crease in the sK current, indicating that CPAdid not directly affect
thepotassiumconductance (forskolin, 63%±23%,n=5; forskolin
+ NS309, 207% ± 41%, n = 5; p < 0.05; CRF, 41% ± 25%, n = 5;
CRF+NS309, 169%±29%,n=5,p<0.05;Figure7D). Thus, func-
tional intracellular calciumstores are essential for PKA-dependent
augmentation of the calcium sensitive potassium channels.
Two Pathways
The outward current induced by activation of metabotropic
glutamate receptors was mediated by two pathways; one is
Figure 4. Both the Aspartate-Induced Current and the Rise in
Dendritic Calcium Are Increased by Forskolin
(A) Image of amidbrain dopamine neuron takenwith a two-photonmicroscope
using the red channel (Alexa Fluor 594, 5 mM). Indicated are the recording elec-
trode (patch), the iontophoretic electrode (iontophoretic), and the dendrite
where the line scan was taken.
(B) Current trace showing the outward current induced by aspartate (L-Asp).
(C) Rise in fluorescence (DG/R) induced by the application of aspartate.
(D and E) Current (D) and fluorescence (E) from the same cell in the presence of
forskolin (3 mM).
(F and G) Overlay of the traces shown in (B and D) and (C and E).
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sensitive to 8-amino-cADP-ribose (cADP/ryanodine receptor-
dependent) (Morikawa et al., 2003). To determine if both path-
ways were sensitive to forskolin, two experiments were pre-
formed. The first experiment was to block IP3 receptors with
intracellular heparin (1 mg/ml) and test the effect of forskolin
on the outward current induced by aspartate. The second exper-
iment was to block cADP-ribose receptors with intracellular
8-amino-cADP-ribose (50 mM).
Under control conditions, forskolin potentiated the aspartate-in-
duced current (control, 31 ± 10 pA; forskolin, 137 ± 10 pA, n = 5
cells/group, p < 0.001; Figures 8A and 8B). Although the inclusion
of heparin or 8-NH2-cADP-ribose reduced the effectiveness of
forskolin by about half, forskolin still caused a significant augmen-
tation (heparin alone, 52 ± 9 pA; heparin + forskolin, 81 ± 14 pA;
n=6, p<0.05; 8-NH2-cADP-ribosealone,49±4pA; 8-NH2-cADP-
ribose + forskolin, 83 ± 10 pA; n = 5, p < 0.01; Figures 8A and 8B).
Thus, forskolin enhanced both ryanodine and IP3 receptor-medi-
ated release of calcium from intracellular stores to increase the ac-
tivationof sK. Further evidence for the redundancyof the twopath-
ways is illustrated in Figure S1, available online. Together these
results imply that the CRF Gs-linked pathway amplifies perhaps
all Gq-receptor-dependent signaling via PKA phosphorylation,
leading to increased release of calcium from intracellular stores.
DISCUSSION
This study demonstrates that in dopamine neurons, the stress
hormone CRF facilitates the release of calcium from intracellular
stores by a PKA-dependent mechanism (Figure 9). Thus, CRF
would augment any mechanism that caused calcium release
from intracellular stores. Given the importance of calcium as
a second messenger, the potential actions of CRF are expected
to be manifold.
The measure used in this study was the activation of a cal-
cium-sensitive potassium conductance that directly regulates
the excitability of dopamine neurons. The local increase in cal-
cium was sufficient to augment the inhibition induced by both
synaptic (mGluR) and intrinsic (after-hyperpolarization) mecha-
nisms. Dopamine neuron excitability is regulated by calcium-
dependent mechanisms (both intrinsic and synaptic), so that
the synergy between Gs- and Gq-coupled systems may repre-
sent a fundamental strategy for shaping neuronal excitability.
CRF Receptors and the CRF-Binding Protein
The increase in sK current induced by CRF was concentration
dependent, significant at a low concentration (1 nM) and depen-
dent on the activation of PKA. The pharmacological experiments
using selective agonists and antagonists indicate that this action
Figure 5. Forskolin Potentiates Both the Current and Rise in
Dendritic Calcium Induced by the Activation of Metabotropic
Glutamate and Muscarinic Receptors
(A) Left side, raw current traces showing the aspartate (L-Asp)-induced
current potentiated by forskolin (3 mM). Right side, summarized results
showing individual experiments (lines) and the averaged results (bars) in
control and during forskolin.
(B) Left side, raw trace of the aspartate-induced increase in fluorescence
(DG/R) and the facilitation caused by forskolin. Right side, summarized
results showing individual (lines) and averaged data (bars) indicated the
facilitation in calcium release induced by forskolin. The fluorescent indica-
tors tested included OGB488-5N (-6-), Fluo5 (-,-), and Fluo4 (-B-).
(C and D) Traces showing results obtained with the iontophoretic appli-
cation of acetylcholine (ACh) in the presence of hexamethonium to acti-
vate muscarinic acetylcholine receptors, using the same protocol as
described in (A) and (B). Statistical significance is signified by *p < 0.05
and ***p < 0.001.
Error bars indicate SEM.
Figure 6. The Forskolin-Induced Increase in Aspartate Current Is
Not Dependent on Extracellular Calcium
(A) Raw current traces showing the outward current induced by aspartate
in control, in calcium-free solution, and in the presence of forskolin (3 mM)
in the calcium-free solution.
(B) Summarized results showing the time course of the experiment. Both
forskolin (3 mM) and CRF (300 nM) caused a significant increase in current
after treatment of the slice with calcium-free solution for 5 min (n = 5). The
calcium-free solution contained EGTA (500 mM). Data in time course are
expressed as a percent of control. Error bars indicate SEM.
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33 resulted in a CRF-R2 receptor-dependent facilitation of the
potassium current, suggesting the presence of endogenous
CRF in these brain slices. Thus, the CRF-binding protein may
hold a reservoir of CRF. Regulation of the interaction between
CRF and the CRF-binding protein may represent a mechanism
by which CRF can be released to activate receptors on dopa-
mine neurons. This observation differs from the PKC-dependent
facilitation of NMDA currents in dopamine neurons that was
blocked by CRF6-33 (Ungless et al., 2003).
Activation of Adenylyl Cyclase Increased Release
of Calcium from Stores
Four different experiments indicated that activation of adenylyl
cyclase potentiates sK currents through increases in cytosolic
calcium, rather than enhancing influx of extracellular calcium.
First, in extracellular solution containing no added calcium (and
inclusion of EGTA), CRF facilitated the sK current evoked by
activation of metabotropic glutamate receptors. Second, cal-
cium-imaging experimentsmeasured local increases in dendritic
calcium, time-locked to facilitation of the sK current. Third,
depletion of intracellular calcium stores with CPA decreased
photolysis-evoked currents and eliminated the CRF- and forsko-
lin-evoked facilitation of sK current. Fourth, blockade of IP3
receptors with heparin or cADP-ribose receptors with 8-amino-
cADP-ribose attenuated the forskolin-evoked increases in the
sK current.
CRF-evoked increases in cytosolic calcium may represent an
elementary action of hormones in general, with the underlying
mechanism dictated by the specific neuron or cell studied. For
instance, in other neuronal or nonneuronal systems, CRF also
Figure 7. Photolytic Release of Caged Calcium Induces an
Outward Current that Is Facilitated by the CRF- and Forskolin-
Evoked Release of Calcium from Intracellular Stores
(A) Raw traces of the outward current induced by photolysis of caged
calcium (flash) in control, CRF (300 nM), and the sK channel stabilizer
NS309 (10 mM).
(B) Summarized results showing the increase in the current evoked by
both forskolin (3 mM, n = 6) and CRF (300 nM, n = 5). Subsequent applica-
tion of NS309 (10 mM) caused a further significant increase in the current
following CRF or forskolin (p < 0.05).
(C) Raw current traces showing that the current resulting from photolysis
of caged calcium is dramatically decreased after depletion of intracellular
calcium stores with cyclopiazonic acid (CPA 10 mM). After CPA, CRF
(300 nM) does not increase the outward current.
(D) Summarized data showing the decline in current induced by CPA and
the blockade of the potentiation induced by forskolin (3 mM, n = 5) and CRF
(300 nM, n = 5). The current was still augmented by NS309 (10 mM).
Data in time courses (B and D) are expressed as a percent of control. Error
bars indicate SEM.
increases intracellular calcium (Dermitzaki et al., 2004; Ka-
geyama et al., 2006; Tao et al., 2006; Yamamori et al.,
2004). The increase in intracellular calcium can result from
the release of calcium from internal stores and/or the activa-
tion of voltage dependent calcium channels (Duridanova
et al., 1999; Haug and Storm, 2000; Huang et al., 2003;
Kanno et al., 1999; Petkova-Kirova et al., 2000). Moreover,
the actual release of calcium may be regulated by multiple
kinases (Fazal et al., 1998; Guerineau et al., 1991; Kim et al.,
2007; Kuryshev et al., 1996; Lee and Tse, 1997; Luini et al.,
1985; Spada et al., 1990; Takuma et al., 1994). Similar results
are reported with CCK, serotonin, vasoactive intestinal peptide,
neurotensin, vasopressin, and norepinephrine (Belmeguenai
et al., 2003; Gaisano et al., 1994; Kudoh et al., 2003; Petersen
et al., 1994; Tse and Lee, 1998). The spatial and temporal prop-
erties of the increases in intracellular calcium, however, vary
considerably with each hormone. The same hormone can gener-
ate global, long-lasting changes in one region of the cell and yet
discrete, short-lasting calcium spikes in another region (Pe-
tersen et al., 1994). Thus, although our results highlight the
actions of CRF and PKA on internal stores at or near dendrites,
we do not exclude other possible actions of CRF in dopamine
neurons.
PKA Regulates Increases in Cytosolic Calcium
ActivationofPKCwith thephorbol ester, PDBu,didnotpotentiate
the sKcurrent. In contrast, the inhibition of PKA (withPKI) blocked
the action of CRF. These results in brain slices are consistentwith
other reports using expression systems to investigate CRF-R2,
urocortin-III, and cAMP (Hsu and Hsueh, 2001; Jahn et al.,
2004; Lewis et al., 2001). The activation of PKA could augment
calcium release through several actions. First, PKA-dependent
phosphorylation is known to increase both the size and the rate
of calcium uptake into the calcium pool (Bruce et al., 2003;
Bugrim, 1999; Furuichi et al., 1994). Second, PKA can directly in-
crease the open probability of ryanodine receptors, which like the
IP3 contains a consensus sequences for PKA (Marx et al., 2000;
Mignery et al., 1990; Sudhof et al., 1991). Third, PKA can
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naling components in close proximity to clusters of IP3 and rya-
nodine receptors (Augustine et al., 2003; Berridge et al., 2003;
Tu et al., 1998). One relevant example is the interaction between
signaling scaffold A-kinase anchoring proteins (AKAPs) and the
hormone vasoactive intestinal peptide (VIP) (Beene and Scott,
2007; Smith et al., 2006). Like CRF, VIP activates Gs, adenylyl
cyclase, cAMP, and PKA (Hagen et al., 2006). The application
of either VIP or a cAMP analog increases the release of calcium
from IP3 receptors. Blockade of ryanodine receptors does not
attenuate release from IP3 receptors. However, either disruption
of AKAPs or the blockade of ryanodine receptors eliminates the
potentiation by both VIP and the cAMP analog (Hagen et al.,
2006). It isconceivable that similaractionscouldbe relevant toCRF.
Implications for Dopamine Neuron Excitability
In many brain regions, recruitment of sK channels regulates syn-
aptic integration and spike frequency adaptation (Bond et al.,
1999; Womack et al., 2004). The importance of calcium in this
process can be inferred from studies in the cerebellumwhere de-
letion of IP3 and ryanodine receptors dramatically disrupts LTD
and impairs synaptic plasticity (Balschun et al., 1999; Inoue
et al., 1998; Taufiq et al., 2005). Such changes predominantly
alter weaker forms of plasticity without affecting neuronal mor-
phology, basal synaptic transmission, or presynaptic function
(Balschun et al., 1999).
In dopamine neurons, opening of the sK channel is precisely
controlled by increases in intracellular calcium arising from two
sources (Bean, 2007; Stocker, 2004). First, synaptic activation
of metabotropic glutamate receptors activates PLC to release
calcium from internal stores that activate sK (Fiorillo and Wil-
liams, 1998; Morikawa et al., 2003). Second, action potentials
activate voltage-gated calcium channels to initiate calcium influx
across the plasma membrane, thus stabilize spiking precision
during increased action-potential firing (Wolfart et al., 2001;
Wolfart andRoeper, 2002). Coordination between these systems
exists, as the calcium released by a burst of action potentials is
potentiated by the increases in IP3 receptor tone initiated byme-
tabotropic glutamate receptors (Cui et al., 2007). Unlike most
neurons in the brain, the axon of dopamine neurons originates
from a dendrite (Grace and Onn, 1989; Hausser et al., 1995).
Consequently, the generation of action potentials in dopamine
cells is dendritic in origin followed by back-propagation into
soma (Gentet and Williams, 2007). This arrangement renders
the dendrite that posses the axon disproportionately important
for generation of action potentials (Gentet and Williams, 2007).
Potentiation of the sK current by CRF in that dendrite would be
predicted to have a strong influence on excitability (Gentet and
Williams, 2007). Thus, CRF could serve as an important coinci-
dence detector to correlate activity inputs by integrating the
calcium originating from action potentials with the release of
Figure 9. Schematic Summarizing the Synergy between Gs- and
Gq-Coupled Receptors in the Regulation of Calcium Release from
Intracellular Stores and Subsequent Activation of sK
Stimulation of Gq-coupled receptors (metabotropic glutamate or the M1-mus-
carinic receptor) activates PLC to activate IP3- and cADP-ribose/ryanodine
receptors to release calcium from intracellular stores. This release of calcium
activates sK channels. The CRF receptor activates adenylate cyclase to
increase cAMP production and stimulate PKA. PKA potentiates the release
of calcium from intracellular stores gated by both IP3 and ryanodine receptors
and thereby increases the outward calcium-sensitive potassium current, sK.Figure 8. Forskolin Recruits Release of Intracellular Calcium via IP3
and Ryanodine Receptors
(A) Raw traces of experiments done under three conditions: control internal
(left), blockade of IP3 receptors with heparin (1mg/ml) containing internal (mid-
dle), and blockade of ryanodine receptors with 8-amino-cADP-ribose (50 mM)
containing internal (right). Each experiment shows the increase in the aspartate
(L-Asp)-induced outward current caused by forskolin (3 mM).
(B) Summarized results showing the average outward current induced by as-
partate and the increase induced by forskolin (n = 5). The facilitation induced
by forskolin (F in each case) was present but reduced in experiments where
IP3 receptors were blocked by heparin or cADP-ribose receptors were
blocked by 8-amino-cADP-ribose (8-Ribose). There was a significant increase
induced by forskolin in each experiment (*p < 0.05), and the forskolin-induced
increase after treatment with heparin and 8-NH2-cADP-ribose was signifi-
cantly smaller from that in control (*p < 0.05 and **p < 0.01). Error bars indicate
SEM.
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tors (Cui et al., 2007; Nakamura et al., 1999).
EXPERIMENTAL PROCEDURES
Slices and Solutions
Slices containing midbrain DA neurons frommale rats (P30-75) were prepared
as described previously (Morikawa et al., 2003). Briefly, horizontal midbrain sli-
ces (220 mm) were cut in ice-cold saline containing 126 mMNaCl, 2.5 mM KCl,
1.2 mM MgCl2, 2.4 mM CaCl2, 1.4 mM NaH2PO4, 25 mM NaHCO3, 11 mM
D-glucose, 0.4 mM ascorbate, and 0.01 mMMK801 using a vibratome (Leica).
Slices were stored in 35C oxygenated (95% O2%–5% CO2) saline containing
MK-801 (10 mM) for 30 min before recording. Electrophysiological recordings
were performed at 35C. The perfusion rate of oxygenated saline (95%
O2%–5% CO2) was 2 ml/min. Neurons were visualized with either an Olympus
BX51WI (Olympus America) or Zeiss Axioskopmicroscope. Microscopeswere
equipped with gradient contrast infrared optics (Dodt et al., 2002).
Whole-Cell Recordings
Whole-cell recordings were made using Axopatch 1D or Axopatch 200A am-
plifiers (Axon Instruments). Neurons were voltage clamped at 60 mV using
1.5–2.0 MU pipettes. Pipette internal solution contained 115 mM K-methylsul-
fate, 20 mM NaCl, 1.5 mMMgCl2, 5 mM HEPES, 2 mM ATP, and 0.3 mM GTP
(pH 7.3; 265–270 mOsm). Unless noted otherwise, internal solution contained
0.1 mM EGTA. Series resistance (3–15 MU) was compensated at 80%. DA
neurons resided <150 mm from the lateral or medial side of the terminal nucleus
of the accessory optic tract (MT). This is a region rich in dopamine cell bodies
(Ford et al., 2006; Wolfart et al., 2001). Recordings from neurons in this region
displayed pacemaker firing (1–2 Hz), broad action potentials (R1.2 ms), and
large H currents (>300 pA at 120 mV) (Fiorillo and Williams, 1998; Ford
et al., 2006; Wolfart et al., 2001). The hyperpolarizing mGluR-mediated current
carried by the sK channel is observed only in dopamine neurons in midbrain
slices (Marino et al., 2001). Though there have been reports of difficulties in
identifying dopamine neurons, the combination of the area in which the record-
ings were made coupled with the criteria used to identify the electrophysiolog-
ical characteristic of dopamine cells indicates that the results are based on
recordings from dopamine cells. Recordings were collected using AxoGraph
X (AxoGraph Scientific) and filtered at 1–2 kHz, digitized at 2–5 kHz.
A monopolar saline-filled glass electrode (3–6 MU) was used to evoke
synaptic release. A train of stimuli (2–5 stimuli, 0.2 ms duration, 40 Hz, once
per minute) was used to evoke IPSCs mediated by the activation of mGluRs
(Fiorillo and Williams, 1998). The mGluR IPSC was isolated pharmacologically
with picrotoxin (100 mM), 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 mM),
CGP55845 (200 nM), sulpiride (1 mM), and MK-801 (10 mM). Iontophoretic ap-
plication of aspartate (200 nA, 5–75 ms) was used to activate postsynaptic
mGluRs. The amplitude of all sK currents were adjusted to approximately
20%–30% of maximum.
Imaging Experiments
Simultaneous calcium imaging and whole cell voltage-clamp recording was
preformed using an electrophysiological setup equipped with a purpose-built
two-photon microscope controlled via Scan Image software (Pologruto et al.,
2003). Neurons were filled for 20–25 min with an internal (K-methylsulfate) so-
lution containing Alexa Fluor 594 (5 mM) and either Fluo4, Fluo5F, or Oregon-
GreenBAPTA488-5N (40 mM). The EGTA in the internal solution was omitted
in these experiments. Alexa Fluor 594 (5 mM), which was not sensitive to cal-
cium, was used to normalize the changes in fluorescence of the calcium-sen-
sitive dye (change in green fluorescence/red fluorescence, DG/R [Sabatini
et al., 2002]). The red fluorescence was also used to visualize the cellular mor-
phology and to identify dendrites 10–45 mm distal to soma where line scans
were taken to measure aspartate induced change in fluorescence. By limiting
the amplitude of the aspartate induced current to 10%–20% of maximum, the
problem of saturating the calcium indicator was reduced. The fluorescence of
dendritic process was measured over a period of 4 s using a line scan. Offline
data analysis was performed using Image-J (NIH) and AxoGraph X (AxoGraph
Scientific). The values of DG/R represent averages of 3–5 line scans surround-ing the maximum changes induced by each drug. Summary data are reported
as mean ± SEM. Significance was defined as p < 0.05, using the two-tailed
Student’s t test.
Photolysis Experiments
Photolysis experiments were conducted using UV pulses supplied by a shut-
tered mercury lamp (100 W, Olympus America) and NP-EGTA (Ellis-Davies
et al., 1996; Ellis-Davies and Kaplan, 1994; Zimmermann et al., 1995). Imme-
diately prior to use, NP-EGTA (1.5 mM) was mixed with CaCl2 (1.2 mM; Neher
and Zucker, 1993) in a K-methylsulfate internal solution lacking EGTA. Solu-
tions were stored at 70C and discarded after 3 days. Neurons were loaded
for 5–10 min prior to photolysis. The amplitude of the flash-evoked current
increased proportionally with increasing shutter duration (12–200 ms). Base-
line amplitudes were adjusted to 10%–20% of the maximum resulting from
a long shutter opening duration (200–400ms). The interval between two pulses
was 2 min to allow re-equilibration of caged compound.
Drugs
DNQX, MK-801, CGP55845, CRF, cyclopiazonic acid (CPA), PKI (6–22) were
obtained from Tocris Bioscience. Heparin and forskolin were purchased
from Calbiochem. Alexa 594, Fluo5F, Fluo4FF, OGB488-5N, and NP-EGTA
were purchased from Invitrogen. All other chemicals were obtained from
Sigma-RBI.
Statistical Analysis
One-way ANOVA was used to determine effects of independent variables, fol-
lowed when appropriate by Tukey’s post hoc test. When only two groups were
involved, comparisons were made with paired t test (within cell). Data are pre-
sented asmean ± SEMwith n designating the number of cells obtained in each
experimental group. In Figure 2A, lines were drawn to illustrate the overall time
course of the action of CRF. All statistical analysis was preformed using Prism
4.03 (GraphPad Software Inc).
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The Supplemental Data for this article can be found online at http://www.
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